Clinical Trial

A Study To Evaluate The Effect Of Rifampicin Or Ltraconazole On Pharmacokinetics Of Ensartinib In Healthy Volunteers

Unknown Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated July 9, 2024 (before its estimated October 2024 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to estimate the effect of rifampicin or itraconazole on the single dose PK of ensartinib.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06492525
Lead Sponsor Betta Pharmaceuticals Co., Ltd.
Conditions Healthy
Enrollment 36 participants
Start Date 2024-07
Primary Completion 2024-10 (estimated)
Study Completion 2024-12 (estimated)
Updated on ClinicalTrials.gov 2024-07-09